Joon Mee Kim

Joon Mee Kim

Auto-generated profile, based on publicly available information

Joon Mee Kim

Department of Pathology, Inha University School of Medicine, Incheon, Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2020 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
BKBaek-Hui Kim
Baek-Hui Kim
JKJoon Mee Kim
Joon Mee Kim
Gyeong-Hoon KangGyeong-Hoon Kang
Gyeong-Hoon Kang
HCHee Jin Chang
Hee Jin Chang
DKDong Wook Kang
Dong Wook Kang
YKYoun Wha Kim
Youn Wha Kim
The first edition of the 'Standardized Pathology Report for Colorectal Cancer,' which was developed by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists, was published 13 years ago. Meanwhile, there have been many changes in the pathologic diagnosis of colorectal cancer (CRC), pathologic findings included in the pathology report, and immunohistochemical and molecular pathology required for the diagnosis and treatment of colorectal cancer. In order to reflect these changes, we (GIP) decided to make the second edition of the report. The purpose of this standardized pathology report is to provide a practical protocol for Korean pathologists, which could help diagnose and treat CRC patients. This report consists of "standard data elements" and "conditional data elements." Basic pathologic findings and parts necessary for prognostication of CRC patients are classified as "standard data elements," while other prognostic factors and factors related to adjuvant therapy are classified as "conditional data elements" so that each institution could select the contents according to the characteristics of the institution. The Korean version is also provided separately so that Korean pathologists can easily understand and use this report. We hope that this report will be helpful in the daily practice of CRC diagnosis.

15 January 2023 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
YPYoung Soo Park
Young Soo Park
MKMyeong-Cherl Kook
Myeong-Cherl Kook
BKBaek-Hui Kim
Baek-Hui Kim
HLHye Seung Lee
Hye Seung Lee
DKDong Wook Kang
Dong Wook Kang
TPThe Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
The first edition of ‘A Standardized Pathology Report for Gastric Cancer’ was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the pathologic diagnosis, molecular genetics, and management of gastric cancer (GC). To reflect those changes, a committee for publishing a second edition of the report was formed within the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. This second edition consists of two parts: standard data elements and conditional data elements. The standard data elements contain the basic pathologic findings and items necessary to predict the prognosis of GC patients, and they are adequate for routine surgical pathology service. Other diagnostic and prognostic factors relevant to adjuvant therapy, including molecular biomarkers, are classified as conditional data elements to allow each pathologist to selectively choose items appropriate to the environment in their institution. We trust that the standardized pathology report will be helpful for GC diagnosis and facilitate large-scale multidisciplinary collaborative studies.

29 January 2019 in Cancers
Verified
Journal Article
Open access
PDF file
NLNguyen Phuoc Long
Nguyen Phuoc Long
KJKyung Hee Jung
Kyung Hee Jung
NANguyen Hoang Anh
Nguyen Hoang Anh
HYHong Hua Yan
Hong Hua Yan
NTNghi Tran
Nghi Tran
SKSung Won Kwon
Sung Won Kwon
Substantial alterations at the multi-omics level of pancreatic cancer (PC) impede the possibility to diagnose and treat patients in early stages. Herein, we conducted an integrative omics-based translational analysis, utilizing next-generation sequencing, transcriptome meta-analysis, and immunohistochemistry, combined with statistical learning, to validate multiplex biomarker candidates for the diagnosis, prognosis, and management of PC. Experiment-based validation was conducted and supportive evidence for the essentiality of the candidates in PC were found at gene expression or protein level by practical biochemical methods. Remarkably, the random forests (RF) model exhibited an excellent diagnostic performance and LAMC2, ANXA2, ADAM9, and APLP2 greatly influenced its decisions. An explanation approach for the RF model was successfully constructed. Moreover, protein expression of LAMC2, ANXA2, ADAM9, and APLP2 was found correlated and significantly higher in PC patients in independent cohorts. Survival analysis revealed that patients with high expression of ADAM9 (Hazard ratio (HR)OS = 2.2, p-value < 0.001), ANXA2 (HROS = 2.1, p-value < 0.001), and LAMC2 (HRDFS = 1.8, p-value = 0.012) exhibited poorer survival rates. In conclusion, we successfully explore hidden biological insights from large-scale omics data and suggest that LAMC2, ANXA2, ADAM9, and APLP2 are robust biomarkers for early diagnosis, prognosis, and management for PC.

25 July 2016 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
BBByoung Wook Bang
Byoung Wook Bang
JPJin Seok Park
Jin Seok Park
HKHyung Kil Kim
Hyung Kil Kim
YSYong Woon Shin
Yong Woon Shin
KKKye Sook Kwon
Kye Sook Kwon
JKJoon Mee Kim
Joon Mee Kim
Background and Aims. There is no consensus so far regarding the optimal endoscopic method for treatment of small rectal neuroendocrine tumor (NET). The aim of this study was to compare treatment efficacy, safety, and procedure time between endoscopic submucosal resection with band ligation (ESMR-L) and endoscopic submucosal dissection (ESD).Methods. We conducted a prospective study of patients who visited Inha University Hospital for endoscopic resection of rectal NET (≦10 mm). Pathological complete resection rate, procedure time, and complications were evaluated.Results. A total of 77 patients were treated by ESMR-L (n=53) or ESD (n=24). En bloc resection was achieved in all patients. A significantly higher pathological complete resection rate was observed in the ESMR-L group (53/53, 100%) than in the ESD group (13/24, 54.2%) (P=0.000). The procedure time of ESD (17.9±9.1 min) was significantly longer compared to that of ESMR-L (5.3±2.8 min) (P=0.000).Conclusions. Considering the clinical efficacy, technical difficulty, and procedure time, the ESMR-L method should be considered as the first-line therapy for the small rectal NET (≤10 mm). ESD should be left as a second-line treatment for the fibrotic lesion which could not be removed using the ESMR-L method.

1 January 2007 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
SCSuk Jin Choi
Suk Jin Choi
JKJoon Mee Kim
Joon Mee Kim
JHJee Young Han
Jee Young Han
SASeung Ik Ahn
Seung Ik Ahn
JKJin-Soo Kim
Jin-Soo Kim
YCYoung Chae Chu
Young Chae Chu
Choi SJ, et al. Yonsei Med J. 2007 Dec;48(6):1066-1071. https://doi.org/10.3349/ymj.2007.48.6.1066

15 July 2021 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
DKDong Wook Kang
Dong Wook Kang
BKBaek-Hui Kim
Baek-Hui Kim
JKJoon Mee Kim
Joon Mee Kim
JKJihun Kim
Jihun Kim
MCMee Soo Chang
Mee Soo Chang
TPThe Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists
Although the understanding of appendiceal mucinous neoplasms (AMNs) and their relationship with disseminated peritoneal mucinous disease have advanced, the diagnosis, classification, and treatment of AMNs are still confusing for pathologists and clinicians. The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists (GPSG-KSP) proposed a multicenter study and held a workshop for the “Standardization of the Pathologic Diagnosis of the Appendiceal Mucinous Neoplasm” to overcome the controversy and potential conflicts. The present article is focused on the diagnostic criteria, terminologies, tumor grading, pathologic staging, biologic behavior, treatment, and prognosis of AMNs and disseminated peritoneal mucinous disease. In addition, GPSG-KSP proposes a checklist of standard data elements of appendiceal epithelial neoplasms to standardize pathologic diagnosis. We hope the present article will provide pathologists with updated knowledge on how to handle and diagnose AMNs and disseminated peritoneal mucinous disease.